Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mind Medicine (MindMed) Inc
MNMD
Alternate Symbol(s):
N.MMED.WS
|
N.MMED.WA
|
N.MMED.WR
|
N.MMED
Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen...
drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MNMD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(128)
•••
Devanand1
X
View Profile
View Bullboard History
Comment by
Devanand1
on Jul 08, 2021 6:13am
RE:It is already worth 2 BILLION CAD
Not sure of this valuation. Seems way too high to me. Company needs to have a few products that generates revenues tha will support the valuation. Will stay away until the valuation
...more
(0)
•••
Moonlighting
X
View Profile
View Bullboard History
Comment by
Moonlighting
on Jul 07, 2021 1:50pm
RE:🐎🐎🐎
What is happening here? What's with the major sell off . Did something expire, creating this? California is passing laws for physiological drugs?
G Mining Ventures Reports Third Quarter 2024 Production and Financial Results
posted Nov 15, 2024 9:00am by
G Mining Ventures Corp.
-
|
"I am proud to reflect on the significant milestones achieved this quarter, from our first gold pour and the launch of commercial production at TZ, to the release of robust PEA results for the generational Oko West project, to the acquisition of the highly prospective CentroGold project in Brazil," commented Louis-Pierre Gignac, President & Chief Executive Officer, "These results ...read more
(800)
•••
SouthernTierTom
X
View Profile
View Bullboard History
Comment by
SouthernTierTom
on Jun 26, 2021 9:53am
RE:Mark G. Gomez CO- Founder Canna Ventures Group LLC $MNMD
Was anything mentioned about actually being "on" said meds in order to understand the valuation? It sounds like the next level of what we have seen up in Canada with the Great Canadien Pot
...more
(2)
•••
HampsStockstar
X
View Profile
View Bullboard History
Post by
HampsStockstar
on Jun 26, 2021 2:11am
Mark G. Gomez CO- Founder Canna Ventures Group LLC $MNMD
Gomez was quoted on Bloomberg radio as saying "psychedelic & mushroom space could see 5-10x returns from current levels". And cited $MNMD, $CLXP $LRSV $ATAI as his current favorites in
...more
(800)
•••
SouthernTierTom
X
View Profile
View Bullboard History
Post by
SouthernTierTom
on Jun 25, 2021 10:54am
It is already worth 2 BILLION CAD
So the article you suggest says 20 BILLION?? WOW .... I haven't dropped ACID since the late 60's, who'd thunk it ? ; - ) And now with the mesacaline and ecstacy studies...maybe 30 or 40
...more
(220)
•••
MrVerbatim9800
X
View Profile
View Bullboard History
Post by
MrVerbatim9800
on Jun 24, 2021 10:28pm
MMED potential for 10X gains... See link below
https://investorplace.com/2021/06/7-best-penny-stocks-to-buy-now-for-potential-10x-gains/
(2)
•••
HampsStockstar
X
View Profile
View Bullboard History
Post by
HampsStockstar
on Jun 21, 2021 8:21pm
$MNMD in article on psychedelics on Cannabishempwire.com
North America Psychedelic Drugs Market Expected to Grow June 8, 2021|#Mushrooms, #Psilocybin The illegal drugs of the 1960's are becoming highly
...more
(0)
•••
Moonlighting
X
View Profile
View Bullboard History
Comment by
Moonlighting
on Jun 17, 2021 1:40pm
RE:MYND Life Sciences Announces LOI with Eyam Vaccines and Immu
hoping to see $5.50 a share soon! And then rocket to $10
(89)
•••
GanjaTrader4
X
View Profile
View Bullboard History
Post by
GanjaTrader4
on Jun 17, 2021 7:12am
MYND Life Sciences Announces LOI with Eyam Vaccines and Immu
https://www.newswire.ca/news-releases/mynd-life-sciences-announces-loi-with-eyam-vaccines-and-immunotherapeutics-896348933.html
(25)
•••
supergarvis
X
View Profile
View Bullboard History
Post by
supergarvis
on Jun 13, 2021 11:32am
PsyKey inc. is about to take off in the psychedelic market …
https://thecannabisstock.com/2021/06/13/psykey-inc-is-about-to-take-off-in-the-psychedelic-market-see-why/
(25)
•••
supergarvis
X
View Profile
View Bullboard History
Post by
supergarvis
on Jun 13, 2021 9:47am
Psychedelic highlights | June 07 – 11
https://thecannabisstock.com/2021/06/13/psychedelic-highlights-june-07-11/
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on Jun 10, 2021 7:35am
Looks like MMD is ready to open open up the valves
https://thedalesreport.com/psychedelics/mindmed-announces-chief-executive-officer-transition/ Excerpt: Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), a leading clinical-stage
...more
(2)
•••
Bullraider
X
View Profile
View Bullboard History
Post by
Bullraider
on Jun 09, 2021 3:36pm
Simple question folks.
Does this company own or lease laboratories?
(9)
•••
oldposty2
X
View Profile
View Bullboard History
Comment by
oldposty2
on Jun 09, 2021 9:21am
RE:Mind Medicine Pays JR Rahn $6.7 Million In Shares To Leave L
thats the answer to the insider selling question, glad its out in the open it should dispell BS speculation about the stock.GOOD RIDDENS
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Jun 09, 2021 7:50am
Mind Medicine Pays JR Rahn $6.7 Million In Shares To Leave L
It seems that after selling $24.7 million in company stock, JR Rahn is looking to step down from Mind Medicine. The firm this morning announced that Rahn will be stepping down from his role as both
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Gold, growth and sustainability in focus for this resource company
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Explained: The Psychology of Options Trading with Practical Tips
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023